Who are Q32 Bio Inc.'s main suppliers?

Q32 Bio Inc. (QTTB) key suppliers include: CANTOR-FITZGERALD-CO, HORIZON-THERAPEUTICS-IRELAND-DAC, OXB-US-LLC, HOMOLOGY. View the full supplier network at chainsifter.com/chain/QTTB.

Who are Q32 Bio Inc.'s major customers?

Q32 Bio Inc. (QTTB) key customers include: OXFORD-BIOMEDICA-US-INC. View the full customer network at chainsifter.com/chain/QTTB.

What sector is Q32 Bio Inc. in?

Q32 Bio Inc. (QTTB) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

QTTB Supply Chain: Q32 Bio Inc. Supplier List & 7 Relationships

4Suppliers

1Customers

2Debt Items

20Related Chains

Q32 Bio Inc. Suppliers

Ticker	Name	Confidence	Evidence
CANTOR-FITZGERALD-CO	CANTOR-FITZGERALD-CO	92%	The Company will pay the Sales Agent a cash commission of 3.0% of gross proceeds from the sale of the Shares pursuant to the Sales Agreement.
HORIZON-THERAPEUTICS-IRELAND-DAC	HORIZON-THERAPEUTICS-IRELAND-DAC	90%	Legacy Q32 was a party to the Horizon Agreements with Horizon, pursuant to which Legacy Q32 received $55.0 million
OXB-US-LLC	OXB-US-LLC	80%	the Company obt ained Homology's 20 % equity interest in OXB (US) LLC, an AAV vector process development and manufacturing services company
HOMOLOGY	HOMOLOGY	70%	The Company concluded that the CVR liability was a derivative liability and was accounted for at fair value. The fair value of the CVR liability was based on significant unobservable inputs, which re…

Q32 Bio Inc. Customers

Ticker	Name	Confidence	Evidence
OXFORD-BIOMEDICA-US-INC	OXFORD-BIOMEDICA-US-INC	90%	On March 1, 2025, Oxford Biomedica (US), Inc. exercised its option to cause the Company to sell and transfer to Oxford Biomedica (US), Inc. all of the Company’s equity ownership interest in OXB (US) LLC

Q32 Bio Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
QTTB-DEBT	Debt stack $13.6M	90%	Market cache reports total debt of $13.6M.
QTTB-DEBT-12020	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.

Q32 Bio Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Q32 Bio Inc..

Q32 Bio Inc. Ownership

Holder	Name	Confidence	Evidence
QTTB-OWNER-ORBIMED-ADVISORS-LLC	ORBIMED ADVISORS LLC	90%	13F overlay lists ORBIMED ADVISORS LLC as top holder; 55 tracked holders.

Q32 Bio Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
EDIT	Editas Medicine, Inc.	100.00	2
ATOS	Atossa Therapeutics, Inc.	100.00	2
CHRS	Coherus Oncology, Inc.	100.00	2
DBVTF	DBV TECHNOLOGIES	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
ALXO	ALX Oncology Holdings Inc.	100.00	2
WHWK	Whitehawk Therapeutics, Inc.	100.00	2
EMMA	Emmaus Life Sciences, Inc.	100.00	2
BLRX	BioLineRx Ltd.	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
CYTK	Cytokinetics, Incorporated	100.00	2
BEAM	Beam Therapeutics Inc.	100.00	2
CBIO	Crescent Biopharma, Inc.	100.00	2
ANRO	Alto Neuroscience, Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
CCEP	Coca-Cola Europacific Partners PLC	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2

Q32 Bio Inc. Supply Chain